Iovance Biotherapeutics (IOVA) Misses Q4 EPS by 1c
Tweet
Share
E-mailGet Alerts IOVA Hot Sheet
Join SI Premium – FREE
Iovance Biotherapeutics (NASDAQ: IOVA) reported Q4 EPS of ($0.18), $0.01 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $86.71 million versus the consensus estimate of $82.03 million.
For earnings history and earnings-related data on Iovance Biotherapeutics (IOVA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Electra Therapeutics files for proposed IPO
- Zentek shares to move from Nasdaq to OTC Markets on Sept. 2
- Goldman Sachs Starts GenFleet Therapeutics Shanghai (2595:HK) at Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
